Zoll-exclusive PNS Technology Included in New CSA Treatment Guidelines
New AASM treatment guidelines for central sleep apnea include the Zoll remedē System's transvenous phrenic nerve stimulation.
New AASM treatment guidelines for central sleep apnea include the Zoll remedē System's transvenous phrenic nerve stimulation.
New AASM treatment guidelines for central sleep apnea include the Zoll remedē System’s transvenous phrenic nerve stimulation.
Read MoreMore than a dozen national organizations are pressing Congress to support the Supplemental Oxygen Access Reform (SOAR) Act, which would ensure Medicare patient access to life-saving oxygen therapy.
Read MoreAs the annual “spring forward” to observe daylight saving time approaches on March 9, new Gallup polling data reveals a majority of Americans want to eliminate the practice.
Read MoreThe AASM issued a statement in response to the FDA’s approval of Zepbound for OSA patients with obesity, highlighting its potential as a new treatment option while cautioning about its limitations and the importance of sustained weight loss.
Read MoreThe American Academy of Sleep Medicine (AASM) has officially launched AASM SleepTM, a new telemedicine platform to increase patient access to board-certified sleep doctors and sleep centers.
Read More